By Ironwood Pharmaceuticals | December 5, 2017Ironwood Pharmaceuticals Reports Topline Phase IIa Data for IW-1973
By Ironwood Pharmaceuticals | August 21, 2017FDA Approves Ironwood Pharmaceutical’s Duzallo to Treat Hyperuricemia in Uncontrolled Gout Patients
